Benlysta: Limited Efficacy for Lupus?

Benlysta: Limited Efficacy for Lupus?

Benlysta is a new lupus treatment being made by Human Genome Sciences along with GlaxoSmithKline.  It is a fully human monoclonal antibody that targets the B-lymphocyte stimulator – BLYS for short – and has shown some efficacy in trials to date. Our analysis, however,...